Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation

NCT05919537 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Pancreatic Cancer
Locally Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

DRUG: HMBD-001
DRUG: Docetaxel
DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

Hummingbird Bioscience